ASCO® 2026 Highlights: Presenter Vignette – Claudio Vernieri
Claudio Vernieri
MD, PhD
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Università degli Studi di Milano & IFOM ETS - The AIRC Institute of Molecular Oncology
1017
Effectiveness of first-line ET+CDK4/6i continuation beyond disease progression in a large cohort of patients with HR+/HER2− advanced breast cancer: Results from the multicenter, real-world, Italian study PALMARES-2.